Workshop I | (Drug Information Simulation Lab) | |
Workshop II | (Medication Misadventure Simulation Lab) | |
Workshop III | (Medication Misadventure Simulation Lab) | |
1st Drug Information Symposium | Dr. Naser Aljaser Pharmacovigilance activates in Saudi Arabia |
Time | Title | |
08:00 - 08:10 | SFH Pharmacy Services at Glance Policy and Procedures of Drug Information Center | |
08:10– 08:30 | Establishing a Drug Information Center/ Scope of Drug Information Service | |
08:50- 09:10 AM | The Systematic Approach to Responding to Drug Information Requests | |
09:10– 09:30 | Classification of Drug Information Resources and the Use the Appropriate Reference in Each Situation. | |
09:30 - 09:50 | Expanding Drug Information Services 937 | |
09:50 – 10:00 | Panel Discussion | |
10:00 – 10:40 | Opening Cermony | |
10:40-11:00 | Ethics and Values Required for DIC Pharmacist and Relation with Medical Companies | |
11:00-11:20 | Integrating Key Performance Indicators (Kpis) And Key Behavioral Indicators (Kbis) For Sustainable Progression | |
11:20 – 11:40 | Communication Skills Required for DI Pharmacist | |
11:40 -12:00 | Pharmacy and Therapeutic Committee | |
12:00 – 12:10 | Panel Discussion | |
13:20-13:40 | Role of Medication Safety Officer | |
13:40-14:00 | Drug Related Problems and Kidney Diseases: A Focus on ADRs | |
14:00-14:20 | Medication Misadventure from Drug Information Perspective | |
14:20-14:40 | Safety of Drugs in Pregnancy & Lactation | |
14:40 – 14:50 | Panel Discussion |
Time | Title | |
08:00-08:20 | Literature Evaluation for Preparing Drug Monograph | |
08:20 - 08:40 | Drug Evaluation Monograph | |
08:40- 09:00 | Strategies for Formulary Development | |
09:00 -09:20 | Medication Use Evaluation Program: An Experience from SFHP-R | |
09:20 -09:40 | Incorporating Pharmaco-economics in Drug Evaluation Monograph | |
09:40 -10: 00 | Hospital Formulary Management Through LexiComp | |
10:00 – 10:20 | Role of Drug Information in Zero Stock Management | |
10:40- 11:00 | Arranging Journal Club for Healthcare Providers | |
11:00- 11:20 | Avoiding Mistakes During GFR Estimation | |
11:20-11:40 | Drug Information in Ambulatory Care | |
11:40 – 12:00 | Bio-originals – Bio-similars: Concept and Uses from Formulary Perspectives | |
12:00 – 12:10 | Panel Discussion | |
13:00-13:20 | Change Management in Dealing with Healthcare Providers | |
13:40-14:00 | Pharmacy Informatics: Enabling Safe and Efficacious Medication Use | |
14:00 -14:30 | New Approaches in Migraine Management |
Time | Title | |
08:00 – 08: 20 | Role of Drug Information in Social Media | |
08:20- 08:40 | Role of Drug Information in Herbal Medicine | |
08:40 - 09:00 | Innovation as a Key Driver for Executing Strategy at Healthcare Organizations | |
09:00 – 09:20 | Counselling Patients with Special Needs | |
09:20 - 09:40 | Collaboration Between Drug Information Centers | |
09:40 -10:00 | Health Technology Assessment (HTA) and my formulary-Determining clinical effectiveness of a pharmaceutical intervention a priori | |
10:00 – 10:10 | Panel Discussion | |
10:20 - 10:40 | Toxicology Cases Reported by DIC | |
10:40 – 11:00 | Analysis and Clinical Findings of Cases Positive for the Novel Synthetic Cannabinoid Receptor Agonist 5F-PB-22 | |
11:00 – 11:20 | High Dose Insulin and Intralipid as New Antidotes. | |
11:20 - 11:40 | Sudden Onset Neurological Deterioration In Infant. Think of Cannabis Intoxication | |
11:40 – 12:00 | Pediatric Accidental Ingestion of Household Products | |
12:00- 12:10 | Panel Discussion | |
13:00-13:20 | AI-Based Cybersecurity Solutions for Healthcare Providers | |
Closing | Closing |
